in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza Bags Manufacturing Contract Using Microreactor Technology
11:26 AM MDT | May 26, 2009 | Deepti Ramesh
Lonza says it has won a manufacturing contract with a big pharma company, and the manufacture of the product will be based on Lonza’s proprietary microreactor technology (MRT), enabling scale-up, clinical trials, and large-scale commercial quantities. Further details of the contract were not disclosed. MRT utilizes continuous flow processes based on plug flow reactors and it requires minimal reagent volumes while offering rapid dynamic responses and robustness, Lonza says. MRT offers new chemical routes, reduced solvent usage, higher yields than...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee